For the first time in 15 years, Downtown Los Angeles will have a new person at the helm of Council District 14. On March 3, Downtown voters will have the opportunity to cast their votes for one of ...
DTLA-One of Downtown’s most heavily connected residents has thrown his hat into the ring in a bid to succeed 14th District City Councilman José Huizar. On Sunday, Oct. 13, Hal Bastian, a local ...
Researchers have uncovered a drug-like compound that blocks a crucial inflammatory pathway, potentially paving the way for a new treatment for a host of diseases -- including COVID-19. The team ...
Defect in antigen processing by epithelial cells, the presence of specific human leukocyte antigen (HLA)-DQ haplotypes together with gliadin’s intrinsic properties, have been recognized as the main ...
A clinical trial testing the safety and efficacy of an investigational monoclonal antibody for treating people who are hospitalized with respiratory disease and low blood oxygen due to infection with ...
PERTH, Australia – Implicit Bioscience Ltd.’s lead candidate, IC-14, is the first anti-CD14 monoclonal antibody (MAb) to progress to the clinic as it enters a phase II trial in the U.S. in COVID-19 ...
Economic impact of progressive disease (PD) following frontline therapy in classical Hodgkin lymphoma (HL). This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not ...
Clinical and analytical performance of non-small cell lung cancer biomarkers. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not include a full text component ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results